1. Home
  2. MNSO vs RYTM Comparison

MNSO vs RYTM Comparison

Compare MNSO & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNSO
  • RYTM
  • Stock Information
  • Founded
  • MNSO 2013
  • RYTM 2008
  • Country
  • MNSO China
  • RYTM United States
  • Employees
  • MNSO N/A
  • RYTM N/A
  • Industry
  • MNSO Department/Specialty Retail Stores
  • RYTM Biotechnology: Pharmaceutical Preparations
  • Sector
  • MNSO Consumer Discretionary
  • RYTM Health Care
  • Exchange
  • MNSO Nasdaq
  • RYTM Nasdaq
  • Market Cap
  • MNSO 5.3B
  • RYTM 4.3B
  • IPO Year
  • MNSO 2020
  • RYTM 2017
  • Fundamental
  • Price
  • MNSO $17.75
  • RYTM $86.70
  • Analyst Decision
  • MNSO Buy
  • RYTM Strong Buy
  • Analyst Count
  • MNSO 4
  • RYTM 13
  • Target Price
  • MNSO $24.40
  • RYTM $88.77
  • AVG Volume (30 Days)
  • MNSO 583.8K
  • RYTM 948.9K
  • Earning Date
  • MNSO 08-29-2025
  • RYTM 08-05-2025
  • Dividend Yield
  • MNSO 3.69%
  • RYTM N/A
  • EPS Growth
  • MNSO 3.84
  • RYTM N/A
  • EPS
  • MNSO 1.09
  • RYTM N/A
  • Revenue
  • MNSO $2,438,853,167.00
  • RYTM $136,863,000.00
  • Revenue This Year
  • MNSO $25.91
  • RYTM $37.56
  • Revenue Next Year
  • MNSO $18.77
  • RYTM $74.99
  • P/E Ratio
  • MNSO $16.64
  • RYTM N/A
  • Revenue Growth
  • MNSO 21.15
  • RYTM 48.88
  • 52 Week Low
  • MNSO $12.51
  • RYTM $40.61
  • 52 Week High
  • MNSO $27.71
  • RYTM $94.80
  • Technical
  • Relative Strength Index (RSI)
  • MNSO 45.34
  • RYTM 76.93
  • Support Level
  • MNSO $17.91
  • RYTM $64.65
  • Resistance Level
  • MNSO $18.75
  • RYTM $94.80
  • Average True Range (ATR)
  • MNSO 0.37
  • RYTM 3.47
  • MACD
  • MNSO 0.02
  • RYTM 2.75
  • Stochastic Oscillator
  • MNSO 41.92
  • RYTM 76.18

About MNSO MINISO Group Holding Limited

MINISO Group Holding Ltd is a value retailer offering a variety of trendy lifestyle products featuring IP design. The principal activity of the Company is investment holding. The company's product categories include home decor, small electronics, textiles, accessories, beauty tools, toys, cosmetics, personal care, snacks, fragrance and perfumes, and stationery and gifts. Its segment includes the MINISO brand, which is engaged in the Design, buying, and sale of lifestyle products, and the TOP TOY brand, which is engaged in the Design, buying, and sale of pop toys. The company generates maximum revenue from the MINISO brand segment. Geographically, it derives a majority of its revenue from China.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

Share on Social Networks: